» Articles » PMID: 31988864

Hepatocellular Carcinoma in Asia: A Challenging Situation

Overview
Specialty Gastroenterology
Date 2020 Jan 29
PMID 31988864
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Amongst the primary tumors of the liver, hepatocellular carcinoma (HCC) is the most common. It is also one of the most prevalent types of cancers in Asia. Mostly, HCC occurs on a background of chronic liver disease and liver cirrhosis; however, de novo HCCs can also arise in apparently normal looking livers on imaging. There are multiple risk factors for HCC, including hepatitis B and C infections, diabetes mellitus, alcohol, and nonalcoholic steatohepatitis. Other common risk factors which are known to be involved in the pathogenesis of HCC are obesity, food contaminated with aflatoxin and hemochromatosis. Many of these factors are commonly found in this part of the world, hence the high burden of disease. Besides these, smoking and familial predisposition to HCC also seem to have an important role to play in its development. Majority of HCC are missed at an early stage despite the emphasis on adequate screening and surveillance strategies. Therefore, most of the time these tumors are diagnosed at a fairly advanced stage, when palliative treatment is the only therapeutic option left. Hence, prevention of HCC by controlling and minimizing the possible risk factors is the need of the hour. Jafri W, Kamran M. Hepatocellular Carcinoma in Asia: A Challenging Situation. Euroasian J Hepatogastroenterol 2019; 9(1):27-33.

Citing Articles

Comparative evaluation of multimarker algorithms for early-stage HCC detection in multicenter prospective studies.

Hou J, Berg T, Vogel A, Piratvisuth T, Trojan J, De Toni E JHEP Rep. 2025; 7(2):101263.

PMID: 39897614 PMC: 11782856. DOI: 10.1016/j.jhepr.2024.101263.


Absorption, metabolism, and excretion of oral [C] radiolabeled donafenib: an open-label, phase I, single-dose study in humans.

Ma S, Yi L, Bian Y, Lv B, Zhang C, Li C Cancer Chemother Pharmacol. 2024; 95(1):5.

PMID: 39673613 DOI: 10.1007/s00280-024-04725-w.


Phase I-IV Drug Trials on Hepatocellular Carcinoma in Asian Populations: A Systematic Review of Ten Years of Studies.

Raghav A, Jeong G Int J Mol Sci. 2024; 25(17).

PMID: 39273237 PMC: 11395253. DOI: 10.3390/ijms25179286.


The Epidemiology, Transmission, Genotypes, Replication, Serologic and Nucleic Acid Testing, Immunotolerance, and Reactivation of Hepatitis B Virus.

Patel A, Dossaji Z, Gupta K, Roma K, Chandler T, Minacapelli C Gastro Hep Adv. 2024; 3(2):139-150.

PMID: 39129942 PMC: 11307719. DOI: 10.1016/j.gastha.2023.10.008.


Attributable liver cancer deaths and disability-adjusted life years in China and worldwide: profiles and changing trends.

Cao M, Xia C, Cao M, Yang F, Yan X, He S Cancer Biol Med. 2024; 21(8).

PMID: 39015006 PMC: 11359490. DOI: 10.20892/j.issn.2095-3941.2024.0149.


References
1.
McGivern D, Lemon S . Virus-specific mechanisms of carcinogenesis in hepatitis C virus associated liver cancer. Oncogene. 2011; 30(17):1969-83. PMC: 3642622. DOI: 10.1038/onc.2010.594. View

2.
Chung R, Baumert T . Curing chronic hepatitis C--the arc of a medical triumph. N Engl J Med. 2014; 370(17):1576-8. DOI: 10.1056/NEJMp1400986. View

3.
Mori M, Hara M, Wada I, Hara T, Yamamoto K, Honda M . Prospective study of hepatitis B and C viral infections, cigarette smoking, alcohol consumption, and other factors associated with hepatocellular carcinoma risk in Japan. Am J Epidemiol. 2000; 151(2):131-9. DOI: 10.1093/oxfordjournals.aje.a010180. View

4.
El-Serag H . Hepatocellular carcinoma: recent trends in the United States. Gastroenterology. 2004; 127(5 Suppl 1):S27-34. DOI: 10.1053/j.gastro.2004.09.013. View

5.
. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004; 363(9403):157-63. DOI: 10.1016/S0140-6736(03)15268-3. View